B Kittner1, P P De Deyn, T Erkinjuntti. Show Affiliations » 1. European/Canadian Propentofylline Study Group, Aventis Pharmaceuticals, Bridgewater, New Jersey 08807, USA.
Abstract
Entities: Disease
Mesh: See more » AgedAlzheimer Disease/drug therapyAlzheimer Disease/physiopathologyAlzheimer Disease/psychologyCognitionDementia, Vascular/drug therapyDementia, Vascular/physiopathologyDementia, Vascular/psychologyDisease ProgressionFemaleHumansMaleNeuroprotective Agents/therapeutic usePatient SelectionPlacebosPsychological TestsXanthines/therapeutic use
Substances: See more » Neuroprotective AgentsPlacebosXanthinespropentofylline
Year: 2000 PMID: 10818549 DOI: 10.1111/j.1749-6632.2000.tb06410.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691